JP2023523872A5 - - Google Patents
Info
- Publication number
- JP2023523872A5 JP2023523872A5 JP2021577862A JP2021577862A JP2023523872A5 JP 2023523872 A5 JP2023523872 A5 JP 2023523872A5 JP 2021577862 A JP2021577862 A JP 2021577862A JP 2021577862 A JP2021577862 A JP 2021577862A JP 2023523872 A5 JP2023523872 A5 JP 2023523872A5
- Authority
- JP
- Japan
- Prior art keywords
- anamycin
- liposomal
- bag
- vial
- vials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962868190P | 2019-06-28 | 2019-06-28 | |
| US62/868,190 | 2019-06-28 | ||
| PCT/US2020/039621 WO2020264161A1 (en) | 2019-06-28 | 2020-06-25 | Method of reconstituting liposomal annamycin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023523872A JP2023523872A (ja) | 2023-06-08 |
| JP2023523872A5 true JP2023523872A5 (enExample) | 2023-07-14 |
| JP7830131B2 JP7830131B2 (ja) | 2026-03-16 |
Family
ID=74061076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021577862A Active JP7830131B2 (ja) | 2019-06-28 | 2020-06-25 | リポソーム化アナマイシンを再構成する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US12257262B2 (enExample) |
| EP (1) | EP3990041B1 (enExample) |
| JP (1) | JP7830131B2 (enExample) |
| KR (1) | KR20220027941A (enExample) |
| CN (2) | CN116785242A (enExample) |
| AU (2) | AU2020302784A1 (enExample) |
| BR (1) | BR112021026480A2 (enExample) |
| CA (1) | CA3144443A1 (enExample) |
| ES (1) | ES3049663T3 (enExample) |
| IL (1) | IL289433B2 (enExample) |
| MX (1) | MX2021015667A (enExample) |
| PL (1) | PL3990041T3 (enExample) |
| SG (1) | SG11202113005SA (enExample) |
| TW (2) | TW202500161A (enExample) |
| WO (1) | WO2020264161A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020264161A1 (en) | 2019-06-28 | 2020-12-30 | Donald Picker | Method of reconstituting liposomal annamycin |
| EP3989978B1 (en) | 2019-06-28 | 2025-12-17 | Board of Regents, The University of Texas System | Preparation of preliposomal annamycin lyophilizate |
| AU2020386092A1 (en) * | 2019-11-21 | 2022-06-16 | Board Of Regents, The University Of Texas System | Lung targeted anticancer therapies with liposomal annamycin |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4927571A (en) | 1987-05-18 | 1990-05-22 | Liposome Technology, Inc. | Preparation of injectable doxorubicin/liposome suspension |
| US4863739A (en) | 1987-05-19 | 1989-09-05 | Board Of Regents, The University Of Texas System | Liposome compositions of anthracycline derivatives |
| IS1685B (is) * | 1990-12-11 | 1998-02-24 | Bracco International B.V. | Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum |
| US5902604A (en) | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
| WO2001032145A1 (en) * | 1999-10-29 | 2001-05-10 | Board Of Regents, The University Of Texas System | Method of cancer treatment |
| AU2004212944B2 (en) * | 2003-02-14 | 2008-08-21 | Children's Hospital & Research Center At Oakland | Lipophilic drug delivery vehicle and methods of use thereof |
| US20130045937A1 (en) * | 2010-03-10 | 2013-02-21 | Cempra Pharmaceuticals, Inc. | Parenteral formulations of macrolide antibiotics |
| PT4241849T (pt) * | 2011-10-14 | 2024-10-30 | Hoffmann La Roche | Utilizações do inibidor da dimerização de her2 pertuzumab e artigo de fabrico que inclui o mesmo |
| KR102284689B1 (ko) * | 2011-10-21 | 2021-08-02 | 셀라토 파마슈티칼즈, 인코포레이티드 | 동결건조된 리포좀 |
| US8926994B2 (en) | 2011-12-07 | 2015-01-06 | The Methodist Hospital Research Institute | Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity |
| WO2016040882A1 (en) | 2014-09-13 | 2016-03-17 | Novartis Ag | Combination therapies of egfr inhibitors |
| KR20170066546A (ko) | 2014-10-03 | 2017-06-14 | 노파르티스 아게 | 조합 요법 |
| CN107569508A (zh) * | 2016-07-05 | 2018-01-12 | 江苏竞诺择生物医药科技有限公司 | 一种治疗造血系统增殖性疾病的药用组合物 |
| AU2017324718B2 (en) * | 2016-09-09 | 2022-09-29 | Irisys, Inc. | Lipsomal anticancer compositions |
| WO2019023873A1 (zh) * | 2017-07-31 | 2019-02-07 | 江苏竞诺择生物医药科技有限公司 | 一种用于治疗造血系统增殖性疾病的纳米脂质微粒组合物及药用组合物 |
| UA129837C2 (uk) | 2018-09-04 | 2025-08-20 | Мінерва Ньюросаєнсиз, Інк. | Способи застосування феноксипропіламінової сполуки для лікування болю |
| WO2020264161A1 (en) | 2019-06-28 | 2020-12-30 | Donald Picker | Method of reconstituting liposomal annamycin |
| EP3989978B1 (en) | 2019-06-28 | 2025-12-17 | Board of Regents, The University of Texas System | Preparation of preliposomal annamycin lyophilizate |
| AU2020386092A1 (en) | 2019-11-21 | 2022-06-16 | Board Of Regents, The University Of Texas System | Lung targeted anticancer therapies with liposomal annamycin |
-
2020
- 2020-06-25 WO PCT/US2020/039621 patent/WO2020264161A1/en not_active Ceased
- 2020-06-25 ES ES20832031T patent/ES3049663T3/es active Active
- 2020-06-25 PL PL20832031.7T patent/PL3990041T3/pl unknown
- 2020-06-25 JP JP2021577862A patent/JP7830131B2/ja active Active
- 2020-06-25 CN CN202310738252.3A patent/CN116785242A/zh active Pending
- 2020-06-25 CN CN202080048890.7A patent/CN114728101B/zh active Active
- 2020-06-25 IL IL289433A patent/IL289433B2/en unknown
- 2020-06-25 BR BR112021026480A patent/BR112021026480A2/pt unknown
- 2020-06-25 SG SG11202113005SA patent/SG11202113005SA/en unknown
- 2020-06-25 AU AU2020302784A patent/AU2020302784A1/en active Pending
- 2020-06-25 KR KR1020227000486A patent/KR20220027941A/ko active Pending
- 2020-06-25 EP EP20832031.7A patent/EP3990041B1/en active Active
- 2020-06-25 CA CA3144443A patent/CA3144443A1/en active Pending
- 2020-06-25 MX MX2021015667A patent/MX2021015667A/es unknown
- 2020-06-29 TW TW113132623A patent/TW202500161A/zh unknown
- 2020-06-29 TW TW109121840A patent/TWI857086B/zh active
-
2021
- 2021-12-17 US US17/554,553 patent/US12257262B2/en active Active
-
2023
- 2023-10-05 US US18/481,951 patent/US11980634B2/en active Active
-
2024
- 2024-05-29 AU AU2024203593A patent/AU2024203593B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2871061C (en) | Ready to be infused gemcitabine solution | |
| EP1052974A2 (en) | Compositions containing organic compounds | |
| AU2024203593B2 (en) | Method of reconstituting liposomal annamycin | |
| US20240189234A1 (en) | Silicon particles for drug delivery | |
| CA3210407A1 (en) | Low-sorbing glyburide formulation and methods | |
| CN104971049B (zh) | 一种含有福沙匹坦的冻干制剂及其制备方法 | |
| CN103877013A (zh) | 一种细辛脑注射剂及其制备方法 | |
| EP2521539A2 (en) | Injectable formulations for parenteral administration | |
| CN104958269B (zh) | 一种兰索拉唑冻干乳剂及其制备方法 | |
| WO2024079565A1 (en) | Stable mitomycin concentrates | |
| HK40063960A (en) | Ready to be infused gemcitabine solution | |
| WO2024225432A1 (ja) | Ｎｍｎ凍結乾燥製剤の製造方法 |